Scientists at Houston Methodist have discovered that a protein linked to neurodegenerative diseases like ALS and dementia also controls a vital DNA repair process. This protein, called TDP43, plays a critical role in how cells fix mistakes in their genetic material. The finding suggests a surprising connection between brain diseases and cancer, potentially changing how researchers understand these major health conditions.[tribuneindia+3]
Key Protein TDP43 Regulates Cell Repair
The study, published in Nucleic Acids Research, shows that TDP43 regulates genes responsible for correcting DNA errors. This repair system, known as DNA mismatch repair, acts like a proofreader. It catches and fixes mistakes that happen when cells copy their genetic information.[tribuneindia+3]
When levels of TDP43 are either too low or too high, these important repair genes become overly active. This heightened activity does not protect cells. Instead, it can harm neurons and make the cell's genetic material unstable. This instability may then increase the risk of cancer.[tribuneindia+4]
Muralidhar L. Hegde, PhD, led the research team. He is a professor of neurosurgery at the Houston Methodist Research Institute's Center for Neuroregeneration. Dr. Hegde explained the broad importance of this discovery. "DNA repair is one of the most fundamental processes in biology," he said.[tribuneindia+4]
Broader Implications for Disease
Dr. Hegde added that TDP43 is not just another protein involved in cell processes. "What we found is that TDP43 is not just another RNA-binding protein involved in splicing, but a critical regulator of mismatch repair machinery," he stated. "That has major implications for diseases like ALS and frontotemporal dementia (FTD) where this protein goes awry."[tribuneindia+4]
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. It affects nerve cells in the brain and spinal cord, leading to loss of muscle control. Frontotemporal dementia (FTD) is a form of dementia that mainly affects the front and sides of the brain, impacting personality, behavior, and language.[tribuneindia+4]
The researchers also found evidence linking TDP43 to cancer. They looked at large databases of cancer information. Their analysis showed that tumors with higher amounts of TDP43 tended to have more genetic mutations.[tribuneindia+4]
Connecting Neurodegeneration and Cancer
This connection suggests that TDP43's role extends beyond brain diseases. "This tells us that the biology of this protein is broader than just ALS or FTD," Dr. Hegde said.[tribuneindia+5]
He emphasized the significance of this dual link. "In cancers, this protein appears to be upregulated and linked to increased mutation load. That puts it at the intersection of two of the most important disease categories of our time: neurodegeneration and cancer," Hegde explained.[tribuneindia+4]
The discovery offers new insights into how these devastating diseases develop. It highlights a shared underlying mechanism. Understanding this broader role of TDP43 could open doors for new treatment strategies.[tribuneindia+4]
Future Treatment Possibilities
The team conducted laboratory experiments to explore potential therapies. They found that by reducing the excessive DNA repair activity caused by abnormal TDP43, they could partially reverse cellular damage.[tribuneindia+3]
Controlling DNA mismatch repair may offer a new way to treat these conditions. This research suggests that targeting the repair process itself could help patients. It provides hope for developing treatments that address both neurodegenerative diseases and certain cancers.[tribuneindia+3]
This groundbreaking work places TDP43 at the center of both neurodegeneration and cancer biology. It points towards a future where treatments might tackle these diseases from a common biological pathway.[tribuneindia+3]
